Scandinavian Medical Solutions AS (SMSMED) — Capital Reinvestment Ratio
Scandinavian Medical Solutions AS (SMSMED) has a Capital Reinvestment Ratio of 0.85x as of September 2024, meaning it reinvests 1% of its operating cash flow (Dkr17.86 Million) in capital expenditures (Dkr15.13 Million). Check Scandinavian Medical Solutions AS (SMSMED) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Scandinavian Medical Solutions AS Capital Reinvestment Ratio (2020–2024)
This chart tracks Scandinavian Medical Solutions AS's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see SMSMED cash flow metrics.
Annual Capital Reinvestment Ratio for Scandinavian Medical Solutions AS (2020–2024)
Year-by-year Capital Reinvestment Ratio for Scandinavian Medical Solutions AS from 2020 to 2024. See SMSMED free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.44x | Dkr3.39 Million | Dkr18.47 Million | ▲ +438250430.7% |
| 2021 | 0.00x | Dkr4.02 Million | Dkr5.00 | ▼ -100.0% |
| 2020 | 1.47x | Dkr9.38 Million | Dkr13.76 Million | — |